Showing results (471-480 of 12,169) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failureJ Wang, G Zhao, W Shen, et al.Journal of Cardiovascular Pharmacology|October 1, 1993
Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearmJ R Cockcroft, D G Sciberras, M R Goldberg, et al.Journal of Cardiovascular Pharmacology|October 1, 1993
Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonistG M Olins, V M Corpus, S T Chen, et al.Journal of Cardiovascular Pharmacology|October 1, 1993
Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteriesJ D Rovin, J S Stamler, J Loscalzo, et al.Journal of Cardiovascular Pharmacology|October 1, 1993
Structural and functional myocardial responses to chronic treatment with the Ca2+ blocker verapamil (Calan-SR) in hypertensive patientsJ W Howley, J M Formolo, D G PenneyJournal of Cardiovascular Pharmacology|October 1, 1993
Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat heartsG J Grover, C A Sargent, S Dzwonczyk, et al.Journal of Cardiovascular Pharmacology|August 1, 1995
Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: a study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia. Almokalant PSVT Study GroupB Darpö, N EdvardssonJournal of Cardiovascular Pharmacology|August 1, 1995
Differential effects of the calcium antagonist mibefradil in epicardial and intramyocardial coronary arteriesC F Küng, M R Tschudi, G Noll, et al.Journal of Cardiovascular Pharmacology|August 1, 1995
Effect of nitric oxide synthase inhibition on bleeding time in humansD I Simon, J S Stamler, E Loh, et al.Journal of Cardiovascular Pharmacology|January 1, 1993
Calcium antagonists-ACE inhibitors combination therapy: objectives and methodology of clinical developmentJ Menard, M BelletPageof 1,217